INTERNATIONAL PATENT: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. FILES APPLICATION FOR "REPROGRAMMING THE CD112-CD112R AXIS FOR OPTIMIZED CANCER IMMUNOTHERAPY"

GENEVA, Aug. 13 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (12902 Magnolia DriveTampa, Florida 33612-9497) filed a patent application (PCT/US2025/014297) for "REPROGRAMMING THE CD112-CD112R AXIS FOR OPTIMIZED CANCER IMMUNOTHERAPY" on Feb 03, 2025. With publication no. WO/2025/166339, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HWU, Patrick (4201 Bayshore Blvd, Unit 1504Tampa, Florida 33611), LUCA, Vincent (1418 Harbour Walk Rd.Tampa, Florida 33602), JULIA, Estefania (13404 Thomasville Cir, Apt CTampa...